| Predicate |
Object |
| contentType |
Comment|Letter |
| endingPage |
6 |
| issn |
0959-8138 |
| issueIdentifier |
7297 |
| pageRange |
1305-6 |
| publicationName |
BMJ (Clinical research ed.) |
| startingPage |
1305 |
| bibliographicCitation |
Stewart R. Riluzole for motor neurone disease. Ambiguous diagnostic criteria mean that wide variations in elgibility may still persist. BMJ. 2001 May 26;322(7297):1305–6. PMID: 11403062. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21207ea6fc7b42df69a19cabd0656e9f |
| date |
2001-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/11403062 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2274
https://portal.issn.org/resource/ISSN/0959-8138 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Riluzole for motor neurone disease. Ambiguous diagnostic criteria mean that wide variations in elgibility may still persist |
| discusses |
http://id.nlm.nih.gov/mesh/M0004295 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000544Q000175 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D002800Q000627
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D003937
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000544Q000188
http://id.nlm.nih.gov/mesh/D018579 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5070 |